Equity Overview
Price & Market Data
Price: $6.71
Daily Change: -$0.253 / 3.78%
Range: $5.80 - $6.96
Market Cap: $44,141,944
Volume: 28,661
Performance Metrics
1 Week: -8.63%
1 Month: -18.21%
3 Months: -55.70%
6 Months: 41.20%
1 Year: -63.68%
YTD: -70.47%
Company Details
Employees: 14
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.